Novonesis AS News - NZM2

Major shareholder announcement

Major shareholder announcement Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has...

Trading by management and close relations of management

Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on...

Major shareholder announcement

Major shareholder announcement June 21, 2024 Company announcement No. 22 Pursuant to Section 30 of the Danish Capital Markets Act...

The era of biosolutions. Outlook upgraded for 2024

The era of biosolutions. Outlook upgraded for 2024 Novonesis is performing very well and the 2024 outlook for pro forma organic sales growth...

Incentive programs for the Executive Leadership Team, the Senior Leadership Team and directors, and other employees

Incentive programs for the Executive Leadership Team, the Senior Leadership Team and directors, and other employees June 6, 2024Company...

Trading by management and close relations of management

Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on...

Trading by management and close relations of management

Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on...

Trading by management and close relations of management

Trading by management and close relations of management In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on...

Trading by management and close relations of management

Trading by management and close relations of management Please read the full announcement in PDF Attachment 2024_16_Trading_By_Management...

Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration

Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration For the first...

Trading statement Q1 2024

Trading statement Q1 2024 Novonesis realized 4% organic sales growth in line with expectations and maintains 2024 outlook. Ester Baiget...

Resolutions from the annual shareholders’ meeting 2024

Resolutions from the annual shareholders’ meeting 2024 Today an ordinary shareholders’ meeting was conducted. The following resolutions...

Invitation to the annual shareholders’ meeting

Invitation to the annual shareholders’ meeting The annual shareholders’ meeting will be held on Tuesday April 30, 2024 at 4:00 pm CET at...

Share-based legacy RSU program granted

Share-based legacy RSU program granted Share-based legacy RSU program granted Novonesis’ Board of Directors has following the merger with...

2024 outlook and pro forma financials

2024 outlook and pro forma financials Novonesis provides outlook for 2024 with expected 5-7% organic sales growth and ~35% adj. EBITDA...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Novonesis AS (NZM2)

Professional-Grade Tools, for Individual Investors.

NZM2 News

Major shareholder announcement

Trading by management and close relations of management

Major shareholder announcement

The era of biosolutions. Outlook upgraded for 2024

Incentive programs for the Executive Leadership Team, the Senior Leadership Team and directors, and other employees

Trading by management and close relations of management

Trading by management and close relations of management

Trading by management and close relations of management

Trading by management and close relations of management

Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration

Trading statement Q1 2024

Resolutions from the annual shareholders’ meeting 2024

Invitation to the annual shareholders’ meeting

Share-based legacy RSU program granted

2024 outlook and pro forma financials

NZM2 Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Novonesis AS (NZM2) News

Novonesis AS (NZM2)

Professional-Grade Tools, for Individual Investors.

NZM2 News

Major shareholder announcement

Trading by management and close relations of management

Major shareholder announcement

The era of biosolutions. Outlook upgraded for 2024

Incentive programs for the Executive Leadership Team, the Senior Leadership Team and directors, and other employees

Trading by management and close relations of management

Trading by management and close relations of management

Trading by management and close relations of management

Trading by management and close relations of management

Q1 update: Novonesis delivers 4% organic sales growth in line with expectations and reports progress on the integration

Trading statement Q1 2024

Resolutions from the annual shareholders’ meeting 2024

Invitation to the annual shareholders’ meeting

Share-based legacy RSU program granted

2024 outlook and pro forma financials

NZM2 Discussion

Your Recent History